155 related articles for article (PubMed ID: 32626916)
1. miR‑199a decreases Neuritin expression involved in the development of Alzheimer's disease in APP/PS1 mice.
Song D; Li G; Hong Y; Zhang P; Zhu J; Yang L; Huang J
Int J Mol Med; 2020 Jul; 46(1):384-396. PubMed ID: 32626916
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
3. Neuritin attenuates cognitive function impairments in tg2576 mouse model of Alzheimer's disease.
Choi Y; Lee K; Ryu J; Kim HG; Jeong AY; Woo RS; Lee JH; Hyun JW; Hahn S; Kim JH; Kim HS
PLoS One; 2014; 9(8):e104121. PubMed ID: 25101829
[TBL] [Abstract][Full Text] [Related]
4. Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
Liu Y; Xu YF; Zhang L; Huang L; Yu P; Zhu H; Deng W; Qin C
CNS Neurosci Ther; 2017 Jul; 23(7):590-604. PubMed ID: 28597477
[TBL] [Abstract][Full Text] [Related]
5. Neuritin can normalize neural deficits of Alzheimer's disease.
An K; Jung JH; Jeong AY; Kim HG; Jung SY; Lee K; Kim HJ; Kim SJ; Jeong TY; Son Y; Kim HS; Kim JH
Cell Death Dis; 2014 Nov; 5(11):e1523. PubMed ID: 25393479
[TBL] [Abstract][Full Text] [Related]
6. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3.
Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL
Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
[TBL] [Abstract][Full Text] [Related]
8. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
9. Distinct Rab7-related Endosomal-Autophagic-Lysosomal Dysregulation Observed in Cortex and Hippocampus in APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.
Ba L; Chen XH; Chen YL; Nie Q; Li ZJ; Ding FF; Zhang M
Chin Med J (Engl); 2017 Dec; 130(24):2941-2950. PubMed ID: 29237927
[TBL] [Abstract][Full Text] [Related]
10. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
[TBL] [Abstract][Full Text] [Related]
11. [Moxibustion improves learning-memory ability by promoting cellular autophagy and regulating autophagy-related proteins in hippocampus and cerebral cortex in APP/PS1 transgenic Alzheimer's disease mice].
Zhu CF; Zhang LD; Song XG; Yang J; Pan HP; He CG; Yang K; Qin XF; Zhu WL
Zhen Ci Yan Jiu; 2019 Apr; 44(4):235-41. PubMed ID: 31056874
[TBL] [Abstract][Full Text] [Related]
12. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
13. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
14. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
15. Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.
Miszczuk D; Dębski KJ; Tanila H; Lukasiuk K; Pitkänen A
Mol Neurobiol; 2016 Dec; 53(10):7010-7027. PubMed ID: 26671618
[TBL] [Abstract][Full Text] [Related]
16. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
[TBL] [Abstract][Full Text] [Related]
17. AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang X; Zhao F; Wang C; Zhang J; Bai Y; Zhou F; Wang Z; Wu M; Yang W; Guo J; Qi J
Neurosci Bull; 2020 Mar; 36(3):254-262. PubMed ID: 31605298
[TBL] [Abstract][Full Text] [Related]
18. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Lee CC; Chang CP; Lin CJ; Lai HL; Kao YH; Cheng SJ; Chen HM; Liao YP; Faivre E; Buée L; Blum D; Fang JM; Chern Y
Mol Neurobiol; 2018 Dec; 55(12):8936-8952. PubMed ID: 29616397
[TBL] [Abstract][Full Text] [Related]
19. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Profiles of the Early Mitochondrial Changes in APP/PS1 and ApoE4 Transgenic Mice Models of Alzheimer's Disease.
He K; Nie L; Zhou Q; Rahman SU; Liu J; Yang X; Li S
J Proteome Res; 2019 Jun; 18(6):2632-2642. PubMed ID: 31055927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
